Replies to post #47030 on Delcath Systems Inc (DCTH)

[SAMNOTSAMUEL]

I certainly believe Simpson would be interested in acceleration out of this mess, the odds though are higher for enrollment issues than FDA allowing data on less than 80 patients from trial. Dilution of the highest order lays closely in wait